Report for: Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial

Title	Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
Published in	PLOS ONE, March 2013
DOI	10.1371/journal.pone.0056400
Pubmed ID	23472071
Authors	Lynn T. Matthews, Sengeziwe Sibeko, Leila E. Mansoor, Nonhlanhla Yende-Zuma, David R. Bangsberg, Quarraisha Abdool Karim
Abstract	Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy.

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	2	50%
Unknown	2	50%

Type	Count	As %
Members of the public	3	75%
Science communicators (journalists, bloggers, editors)	1	25%

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Researcher	19	17%
Student > Master	19	17%
Student > Ph. D. Student	15	13%
Student > Postgraduate	8	7%
Student > Bachelor	7	6%
Other	18	16%
Unknown	28	25%

Readers by discipline	Count	As %
Medicine and Dentistry	39	34%
Social Sciences	16	14%
Nursing and Health Professions	9	8%
Psychology	4	4%
Pharmacology, Toxicology and Pharmaceutical Science	4	4%
Other	10	9%
Unknown	32	28%

PLOS